Drug prioritization identifies panobinostat as a tailored treatment element for patients with metastatic hepatoblastoma

Abstract Background Patients with metastatic hepatoblastoma are treated with severely toxic first-line chemotherapies in combination with surgery. Yet, inadequate response of lung metastases to neo-adjuvant chemotherapy still compromises patient outcomes making new treatment strategies, tailored to...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Salih Demir, Alina Hotes, Tanja Schmid, Stefano Cairo, Emilie Indersie, Claudio Pisano, Eiso Hiyama, Tomoro Hishiki, Christian Vokuhl, Sophie Branchereau, Penelope Brock, Irene Schmid, József Zsiros, Roland Kappler
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2024-11-01
Edice:	Journal of Experimental & Clinical Cancer Research
Témata:	Hepatoblastoma Metastasis Panobinostat Therapy MYC
On-line přístup:	https://doi.org/10.1186/s13046-024-03221-6
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!